Rapid Evidence Synthesis: Protein-Depletion–Driven Postoperative Edema, Glycocalyx Dysfunction, and Diuretic Refractoriness

Rapid Evidence Synthesis: Protein-Depletion–Driven Postoperative Edema, Glycocalyx Dysfunction, and Diuretic Refractoriness Jaya Z. Moore, BA (Duke University)a, ajaya.po[email protected]e.edu This manuscript was compiled on November 18, 2025 Rapid postoperative albumin decline, interstitial fluid accumulation, and diuretic refractoriness often co-occur in high-permeability states. Despite this, perioperative management paradigms frequently conceptualize postoperative edema as a simple fluid-excess problem rather than a protein-loss problem driven by increased capillary escape of albumin and glycocalyx degradation. Rapid Evidence Synthesis is an established methodology for supporting time-sensitive healthcare decisions by summarizing heterogeneous evidence without the delays inherent to full systematic reviews. This working paper applies that method to the emerging clinical phenotype of postoperative protein-depletion edema. P ostoperative third-spacing and pulmonary edema are frequently managed as a pure fluid-excess problem. The literature indicates a recurring mechanistic pattern in which surgical stress and inflammation damage the endothelial glycocalyx, accelerate transcapillary albumin escape, and precipitate hypoalbuminemia. This oncotic collapse promotes continued leak and diuretic refractoriness until protein is restored and endothelial barrier function improves [4] [2] [7]. 1. Literature patterns: diuretic failure and response to protein-directed therapy 1.1. Hypoalbuminemic ALI/ARDS. A randomized trial of furosemide with vs without albumin in hypoproteinemic acute lung injury showed that albumin coadministration increased diuresis, improved oxygenation, and reduced furosemide - associated hypotension versus furosemide alone, despite small sample size [ 3 ]. Narrative and meta-analytic syntheses report that albumin plus loop diuretic enhances diuresis and natriuresis in hypoalbuminemic patients, with stronger signals at lower albumin levels, larger albumin doses, or impaired renal function [8] [7]. 1.2. ARDS/peri-ICU strategies. Reviews emphasize that deresuscitation with diuretics, ultrafiltration, and in selected hypoalbuminemic patients hyperoncotic albumin support, reduces ventilation days and ICU stay; ARDS guidance notes that albumin+furosemide may accelerate fluid mobilization vs diuretic alone by approximately 1–2 days in appropriate phenotypes [7] [6]. 1.3. Perioperative third-spacing. Cardiac-surgery reviews document rapid postoperative transcapillary albumin escape and positive fluid balances; strategies include limiting crystalloid, goal - directed therapy, and considering colloid/hyperoncotic albumin during deresuscitation to restore colloid osmotic pressure [4], [7]. 2. Mechanistic pathways supporting a protein-first hypothesis 2.1. Glycocalyx injury and capillary leak. Surgical ischemia–reperfusion, inflammation, hypervolemia/ANP, and oxidative stress damage the endothelial glycocalyx, increasing permeability to macromolecules including albumin; perioperative cohorts demonstrate syndecan - 1/heparan sulfate elevation and high transcapillary escape of albumin [2] [4]. 2.2. Oncotic collapse and diuretic resistance. Low plasma albumin reduces colloid oncotic pressure, collapsing effective circulating volume; in high - permeability states, diuretics remove intravascular fluid while leak persists, limiting durable decongestion unless protein is restored. Hyperoncotic albumin can transiently raise oncotic pressure, support hemodynamics, and augment diuretic responsiveness, although permeability blunts colloid efficacy in severe leak [8] [7] [6]. Significance Statement Postoperative pulmonary edema and generalized third-spacing are commonly managed as problems of excess fluid, with treatment centered on diuretics and drainage. Emerging mechanistic evidence suggests that a subset of cases represents protein-depletion–driven capillary leak, characterized by rapid postoperative albumin decline, endothelial glycocalyx injury, and limited response to loop diuretics. This Rapid Evidence Synthesis summarizes relevant perioperative, critical care, and endothelial biology literature; identifies patterns of diuretic failure associated with hypoalbuminemia and increased vascular permeability; and proposes a conceptual framework linking surgical stress, dysautonomia, capillary fragility, and intravascular oncotic collapse. The paper includes a pragmatic phenotype checklist and outlines a prospective study protocol designed to test whether early protein restoration (hyperoncotic albumin ± optimized nutrition) improves decongestion and clinical outcomes in postoperative patients with refractory edema. This working paper is intended to support timely clinical reasoning and to provide a foundation for future empirical study. 2To whom correspondence should be addressed. E-mail: jaya.powellalumni.duke.edu https://doi.org/10.5281/zenodo.17643651 BRI | November 18, 2025 | vol. 2025 | no. 1118 | 1–4 2.3. Endothelial mediators and stress axes. In sepsis-like capillary leak, ANG2/ANG1 imbalance, heparin - binding protein, and S1P/apoM track permeability and fluid balance; these pathways plausibly operate perioperatively and are aggravated by catecholamine surges [5]. 3. Phenotypic markers that may predict diuretic failure • Baseline/trajectory hypoalbuminemia and rapid postoperative albumin decline ([4], [7]). • Glycocalyx shedding markers (syndecan-1, heparan sulfate) elevated perioperatively ([2]). • Endothelial leak markers: ANG2 and ANG2/ANG1 ratio, HBP; potential barrier modulators S1P/apoM ([3]). • ARDS monitoring indices: extravascular lung water, net fluid balance, and responsiveness to small albumin+diuretic tests ([8], [4]). • Furosemide pharmacodynamics modulated by albumin binding capacity and concentration, suggesting ABiC as a candidate predictor for loop diuretic response ([7]). • Clinical phenotype for an enriched subpopulation: refractory edema despite reasonable diuretics/drainage, orthostatic intolerance with exaggerated tachycardia (suggesting dysautonomia), easy bruising/poor wound healing suggestive of connective tissue fragility; these are mechanistically consistent but require prospective validation ([4], [2], [3]). 4. Interventional evidence comparing diuretic-first vs albumin+diuretic or protein-first • Randomized trial in hypoproteinemic ALI: albumin+furosemide outperformed furosemide alone on diuresis and oxygenation with fewer hypotensive events ([8]). • Meta-analytic and narrative syntheses: Benefit for albumin+loop diuretic vs. loop diuretic alone in hypoalbuminemia, with contextual factors (dose, albumin level, renal function) influencing effect size ([7], [4], [8]). • De-resuscitation frameworks: Reviews recommend combining hyperoncotic albumin with diuretics in hypoalbuminemic, fluid-overloaded ICU patients, and escalating to ultrafiltration when needed; these strategies shorten ventilator days and ICU stay in observational data ([ 4 ], [3]). • Evidence limitations regarding EDS/dysautonomia: Direct perioperative case series explicitly linking undiagnosed Ehlers–Danlos or hypermobility to postoperative diuretic-refractory edema are sparse in the retrieved corpus. Nevertheless, perioperative glycocalyx/capillary-leak biology and the observed benefit of albumin+diuretics in hypoalbuminemic leak states render the hidden-fragility hypothesis plausible and testable with targeted phenotyping ([4], [2], [3]). 5. Evidence synthesis Below is a concise, literature-linked artifact summarizing five key clinical patterns, mechanistic links, interventions that have empirical signal, candidate biomarkers, and pragmatic phenotypic flags for a prospective protocol testing the "proteinfirst" hypothesis in postoperative, diuretic-refractory edema. 5.0.1. Hypoalbuminemic acute lung injury / pulmonary edema with poor diuretic response. • Representative evidence: Small RCT of furosemide ± albumin showing improved diuresis, oxygenation, and fewer hypotensive events ([ 8 ]); meta-analyses/pilot trials demonstrating benefit of albumin+loop diuretics in hypoalbuminemia ([7], [4]). • Mechanistic link: Low oncotic pressure + high permeability → intravascular collapse and persistent leak; diuretics remove water but cannot restore oncotic gradient ([7], [2]). • Interventions: Hyperoncotic 20% albumin timed with loop diuretics; ultrafiltration/RRT if diuretics fail ([ 8 ], [ 3 ], [4]). • Biomarkers: Serum albumin trajectory, EVLW, net fluid balance, hemodynamics; albumin:CRP or albumin:lactate ratios ([4], [3]). 5.0.2. Perioperative capillary leak / third-spacing (cardiac, major abdominal surgery). • Representative evidence: Reviews note intraoperative glycocalyx shedding and rapid postoperative albumin escape ([2], [4]). • Mechanistic link: Surgical stress, SIRS, ANP release → EG shedding → increased protein permeability and oncotic collapse ([2], [4]). • Interventions: Goal-directed therapy, restricted crystalloids, colloid/hyperoncotic albumin during deresuscitation; multiple trials underway ([7], [4]). • Biomarkers: Syndecan-1, heparan sulfate, albumin kinetics, transcapillary escape rate ([2], [4]). 5.0.3. Diuretic-resistant third-spacing in chronic high-permeability states (cirrhosis, nephrotic syndrome, PLE). • Representative evidence: Cirrhosis/ascites management shows diuretic resistance requiring paracentesis, albumin replacement, and nutritional support ([7], [4]). • Mechanistic link: Ongoing protein loss (renal, GI, transcapillary) lowers COP; third spaces fill faster than diuretics can offload ([7], [4]). • Interventions: Paracentesis, albumin replacement, enteral/TPN, ultrafiltration if refractory ([7], [4]). • Biomarkers: Serum albumin, urine protein, fecal α 1– antitrypsin clearance; response to albumin+diuretic challenge ([7]). 2| https://doi.org/10.5281/zenodo.17643651 Moore 5.0.4. Systemic capillary leak / sepsis-like phenotypes and neurohormonal drivers. • Representative evidence: ANG2/Tie2, HBP, and S1P/apoM linked to vascular leak in shock states ([3]). • Mechanistic link: ANG2↑and HBP disrupt the barrier; catecholamine surges or dysautonomia worsen permeability ([3], [2]). • Interventions: Albumin resuscitation in select sepsis subgroups, vasoactive strategies, RRT during reabsorption phase ([3], [4]). • Biomarkers: ANG2/ANG1 ratio, HBP, S1P/apoM, vasopressor needs, syndecan-1 ([3], [2]). 5.0.5. Hypothesized hidden connective-tissue fragility subgroup (EDS/hypermobility). • Representative evidence: Perioperative EDS sources note dysautonomia and fragility but few systematic reports of diuretic-refractory edema ([4], [2], [3]). • Mechanistic link: Baseline capillary fragility + exaggerated inflammatory/catecholamine response →disproportionate EG injury and rapid albumin loss ([ 2 ], [ 4 ], [7]). • Interventions: Early albumin repletion paired with loop diuretics, aggressive protein support (TPN/EN), early ultrafiltration if unstable ([7], [4], [3]). • Phenotypic markers: Rapid albumin drop, refractory edema, POTS/orthostatic tachycardia, easy bruising, poor wound healing ([4], [2], [3]). 5.1. Practical, evidence-linked takeaways. • There is consistent physiologic and trial-level signal that the combination of hypoalbuminemia + increased capillary permeability produces a state in which loop diuretics have reduced effectiveness. Across RCTs and meta-analytic syntheses, albumin co-administration frequently restores diuresis, improves oxygenation, and reduces hypotensive episodes in selected patients ([ 8 ], [ 7 ], [4]). • Mechanistic markers that operationalize this biology for clinical decision-making include: syndecan-1/heparan sulfate (glycocalyx shedding), ANG2/HBP (endothelial activation and permeability), S1P/apoM (barrier stabilization), and measures of albumin kinetics. These should be prioritized in any prospective test of the proteinfirst hypothesis ([2], [3], [4]). • Direct literature explicitly linking undiagnosed Ehlers–Danlos syndrome (EDS)/hypermobility to postoperative diuretic-refractory pulmonary edema or third-spacing is limited. However, the proposed mechanistic pathway—baseline connective-tissue and capillary fragility amplified by perioperative inflammatory/catecholamine stress and accelerated glycocalyx injury—is biologically plausible and testable with targeted phenotyping ([4], [2], [3]). 6. Proposed study design 6.1. Key biomarkers and measurements to collect in a prospective test of the hypothesis (minimum set). • Serum albumin (baseline and every 12–24 h early postop) and albumin:CRP ratio [7] • Syndecan - 1 and heparan sulfate (glycocalyx shedding markers) preop, immediate postop, POD1–3 [2] • ANG2 and ANG1 (compute ANG2/ANG1 ratio), plasma HBP, S1P/apoM [5] • Urine sodium and timed urine output per diuretic dosing; net fluid balance and EVLW or bedside lung ultrasound when possible [6] • Albumin-binding function (ABiC) and furosemide pharmacokinetic sampling in a subset (promising for predicting diuretic response) [8] [1] 6.2. Phenotypic screening flags to identify candidate "hidden EDS/dysautonomia" cases (for enriched enrollment). • Unexpected rapid postop decline in serum albumin despite adequate nutrition. • Large-volume third-spacing (pulmonary edema, anasarca, refractory pleural/ascitic effusions) that recurs despite reasonable diuretic dosing and drainage. • Autonomic features: disproportionate sinus tachycardia, POTS - like orthostatic intolerance, labile blood pressure or high vasopressor/catecholamine requirements ([ 4 ], [ 2 ]). • Historical/exam clues: family history of hypermobility/poor wound healing, easy bruising, recurrent hernias or mucocutaneous fragility ([7]). 6.2.1. Suggested immediate, hypothesis-driven clinical actions when encountering such cases (pragmatic, low-risk bundle).. 1. Check serum albumin and trend (stat) and measure urine sodium/diuretic response after optimized loop dosing. 2. If albumin < 30 g/L (or rapid drop from baseline) with ongoing edema despite diuretics, consider a trial of hyperoncotic albumin (20%) administered within 1–2 hours before/with loop diuretic and monitor hemodynamic response and urine output closely (evidence from RCT/pilot data supports physiologic benefit) [3] [7] 3. If diuretic+albumin fails or hemodynamics prevent escalation, consider early RRT/ultrafiltration for fluid removal in appropriate patients [6] [7] 4. Evaluate for causes of protein loss (urine protein, stool PLE testing) and consider early nutrition/protein support (EN/TPN) if PLE suspected [7] Moore BRI | November 18, 2025 | vol. 2025 | no. 1118 | 3 6.3. Prospective trial design. Objective: Determine whether early protein restoration improves decongestion vs. diureticfirst care. Design: Pragmatic multicenter RCT; 1:1 randomization; adaptive enrichment. Population: • postop ≤ 7 days + positive fluid balance (pulmonary edema/anasarca/effusions) • loop diuretics ≥ 1–2 mg/kg furosemide-equivalent with UOP <0.5 mL/kg/h or <1L/day • albumin ≤ 30–32 g/L or ≥ 20% drop; exclude LV-dominant cardiogenic edema or immediate-RRT AKI Primary endpoint: VFDs to day 28 (if ventilated) or ΔEVLW / ΔPaO2/FiO2at 72h ([8], [7]). Secondary endpoints: Net fluid balance at 72h; diuretic efficiency; RRT initiation; ICU/hospital LOS; instability episodes; 28-day mortality ([4], [3]). Mechanistic biomarkers (0, 6–12h, 24h, 48h, 72h): albumin; syndecan-1/heparan sulfate; ANG2/ANG1; HBP; S1P/apoM; ABiC; furosemide PK ([2], [3], [4], [8]). Enrichment variables: Orthostatic vitals; autonomic indices; hypermobility/fragility flags ([4], [2]). Sample size: VFD + net fluid balance assumptions → 86–130/arm; target 200–260 total; pilot n ≈ 60 for variance estimates ([7], [8]). Conclusions Across perioperative/ICU literature, clusters of diuretic refractoriness co-occur with hypoalbuminemia and endothelial leak. Adding hyperoncotic albumin to loop diuretics improves diuresis and oxygenation in hypoalbuminemic lung-injury cohorts, and de - resuscitation frameworks support albumin - augmented diuresis with escalation to ultrafiltration when needed [ 3 ] [ 7 ] [6]. Mechanistic studies demonstrate perioperative glycocalyx shedding, elevated transcapillary albumin escape, and endothelial mediator shifts that rationalize a protein - first approach in selected patients [2] [4] [5]. Direct perioperative EDS/dysautonomia case clusters are limited in the retrieved set; however, a targeted prospective trial with endothelial and albumin - kinetic biomarkers, diuretic - efficiency endpoints, and phenotypic enrichment is feasible and would decisively test whether early protein restoration improves outcomes in refractory postoperative edema [ 2 ] [7] [6]. References [1] PD Courtney Feagin and PGYP Resident. Albumin it to win it: Use of albumin in adult icu patients. Unknown journal, 2025. [2] Jan Jedlicka, Bernhard F. Becker, and Daniel Chappell. Endothelial glycocalyx. Critical Care Clinics, 36:217–232, Apr 2020. ISSN 0749-0704. . URL https://doi.org/10.1016/j. ccc.2019.12.007. [3] Greg S. Martin, Marc Moss, Arthur P. Wheeler, Meredith Mealer, John A. Morris, and Gordon R. Bernard. A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury*. Critical Care Medicine, 33:1681–1687, Aug 2005. ISSN 0090-3493. . URL https://doi.org/10.1097/01.ccm. 0000171539.47006.02. [4] Stefano Romagnoli, Alessandra Rizza, and Zaccaria Ricci. Fluid status assessment and management during the perioperative phase in adult cardiac surgery patients. Journal of cardiothoracic and vascular anesthesia, 30 4:1076–84, Aug 2016. ISSN 1053-0770. . URL https://doi.org/10.1053/j. jvca.2015.11.008. [5] James A. Russell, Barret Rush, and John Boyd. Pathophysiology of septic shock. Critical care clinics, 34 1:43–61, Jan 2018. ISSN 0749-0704. . URL https://doi.org/10.1016/j. ccc.2017.08.005. [6] Philippe Vignon, Bruno Evrard, Pierre Asfar, Mattia Busana, Carolyn S. Calfee, Silvia Coppola, Julien Demiselle, Guillaume Geri, Mathieu Jozwiak, Greg S. Martin, Luciano Gattinoni, and Davide Chiumello. Fluid administration and monitoring in ards: which management? Intensive Care Medicine, 46:2252–2264, Nov 2020. ISSN 0342-4642. . URL https://doi.org/10.1007/s00134-020-06310-0. [7] Christian J. Wiedermann. Phases of fluid management and the roles of human albumin solution in perioperative and critically ill patients. Current Medical Research and Opinion, 36:1961–1973, Nov 2020. ISSN 0300-7995. . URL https://doi.org/10.1080/03007995.2020.1840970. [8] Markus Zdolsek. Volume effects of albumin infusion in humans. Linköping University Medical Dissertations, May 2023. ISSN 0345-0082. . URL https://doi.org/10.3384/ 9789180750875. 4| https://doi.org/10.5281/zenodo.17643651 Moore